Cancer: It’s personal, and not only on an emotional level, but a molecular one. Every patient's cancer is unique, driven by distinct biological factors. So, too, should every patient’s treatment. Read more
Himisha Beltran and Christopher Barbieri were awarded Challenge Awards from the Prostate Cancer Foundation, two of only six distributed nationwide. Read more
Gail Roboz, director of the Leukemia Program, presented an educational platform discussing the introduction of epigenetic and personalized therapies targeting AML at the ASH Annual Meeting. Read more
Jia Ruan, M.D., Ph.D., talks to OncLive about the results of a phase II study that show sustained remissions experienced by patients treated with the combination of lenalidomide and rituximab as initial treatment for mantle cell lymphoma (MCL). Read more
Researchers have discovered more information about an elusive part of our cells, which could lead to a better understanding of how prostate cancer develops. Read more
Selina Chen-Kiang, Ph.D., was among 12 scientists selected from across the nation to receive a $600,000 award to promote translational cancer research. Read more
Gail J. Roboz, M.D., discusses the status of research into acute myeloid leukemia during a presentation at the 2014 Chemotherapy Foundation Symposium. Read more
Researchers at Weill Cornell Medical College in Qatar have made a major step towards understanding why certain cancers often recur after they have been treated with conventional therapies. Read more
David Lyden’s blood test to isolate cancer released exosomes was one of six projects selected as winners of the inaugural Daedalus Fund for Innovation. Read more
A feature in Weill Cornell Medicine highlights some of the work being done by John Leonard, Leandro Cerchietti, Ari Melnick and others at the Meyer Cancer Center to tailor treatments to individual patients. Read more
Race and ethnicity dramatically influence patients' end-of-life preferences, which affect the likelihood they will complete a do-not-resuscitate order. Read more
Work by Andrea Shoner and his team has demonstrated that organ tissue derived from human prostate cancer tumors can be grown in the laboratory, giving researchers a new tool to test cancer drugs and personalize cancer treatment. Read more
“Once-in-a-generation” researcher John Blenis joins the Meyer Cancer Center team as Anna-Maria and Stephen Kellen Professor of Cancer Research. Read more
A research team led by Selina Chen-Kiang has revealed key insights into why late resistance to breakthrough drug ibrutinib occurs in many mantle cell lymphoma patients, and has shown preclinical success with two new treatment strategies. Read more